2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Solid-Phase Synthesis of Biaryl Cyclic Lipopeptides Derived from Arylomycins

      research-article
      , , , ,
      ACS Omega
      American Chemical Society

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          An efficient approach for the solid-phase synthesis of N-methylated tailed biaryl cyclic lipopeptides based on the structure of arylomycins was established. Each of these analogues incorporates an N-terminal linear lipopeptide attached to a biaryl cyclic tripeptide containing a Phe–Tyr, a Tyr–Tyr, or a His–Tyr linkage. This methodology first involved an intramolecular Suzuki–Miyaura arylation of a linear peptidyl resin incorporating the corresponding halogenated amino acid at the N-terminus and a boronotyrosine at the C-terminus. After N-methylation of the resulting biaryl cyclic peptidyl resin, the N-methylated lipopeptidyl tail was then assembled. The biaryl cyclic lipopeptides were purified and characterized.

          Related collections

          Most cited references45

          • Record: found
          • Abstract: not found
          • Article: not found

          Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Selection of boron reagents for Suzuki-Miyaura coupling.

            Suzuki-Miyaura (SM) cross-coupling is arguably the most widely-applied transition metal catalysed carbon-carbon bond forming reaction to date. Its success originates from a combination of exceptionally mild and functional group tolerant reaction conditions, with a relatively stable, readily prepared and generally environmentally benign organoboron reagent. A variety of such reagents have been developed for the process, with properties that have been tailored for application under specific SM coupling conditions. This review analyses the seven main classes of boron reagent that have been developed. The general physical and chemical properties of each class of reagent are evaluated with special emphasis on the currently understood mechanisms of transmetalation. The methods to prepare each reagent are outlined, followed by example applications in SM coupling.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Cyclic peptide therapeutics: past, present and future.

              Cyclic peptides combine several favorable properties such as good binding affinity, target selectivity and low toxicity that make them an attractive modality for the development of therapeutics. Over 40 cyclic peptide drugs are currently in clinical use and around one new cyclic peptide drug enters the market every year on average. The vast majority of clinically approved cyclic peptides are derived from natural products, such as antimicrobials or human peptide hormones. New powerful techniques based on rational design and in vitro evolution have enabled the de novo development of cyclic peptide ligands to targets for which nature does not offer solutions. A look at the cyclic peptides currently under clinical evaluation shows that several have been developed using such techniques. This new source for cyclic peptide ligands introduces a freshness to the field, and it is likely that de novo developed cyclic peptides will be in clinical use in the near future.
                Bookmark

                Author and article information

                Journal
                ACS Omega
                ACS Omega
                ao
                acsodf
                ACS Omega
                American Chemical Society
                2470-1343
                04 September 2020
                15 September 2020
                : 5
                : 36
                : 23401-23412
                Affiliations
                [1]LIPPSO, Department of Chemistry, University of Girona , Maria Aurèlia Capmany 69, 17003 Girona, Spain
                Author notes
                Article
                10.1021/acsomega.0c03352
                7496001
                32954193
                b324775a-d941-4c18-be51-7b5ad632b642
                Copyright © 2020 American Chemical Society

                This is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

                History
                : 13 July 2020
                : 12 August 2020
                Categories
                Article
                Custom metadata
                ao0c03352
                ao0c03352

                Comments

                Comment on this article